Developing drugs to
halt the progression of neurodegenerative disease.

Our platform for target and drug discovery combines two areas of unique expertise to find progression-related targets:

• Proprietary computational tools and techniques to derive new biological insights from small and sparse data sets
• Pioneering CNS stem-cell models that recapitulate “progression” in vitro to select targets and drive drug discovery